Your browser doesn't support javascript.
loading
A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia, C R; Pedersen, B; Hitt, M; Burdin, N; Sercarz, E E; Graham, F L; Gauldie, J; Braciak, T A.
Affiliation
  • Gabaglia CR; Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA. claudia@liai.org
J Immunol ; 162(2): 753-60, 1999 Jan 15.
Article in En | MEDLINE | ID: mdl-9916695
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Adenoviridae / Interleukin-4 / Leishmaniasis, Cutaneous / Leishmania major / Interleukin-12 / Genetic Vectors Limits: Animals Language: En Journal: J Immunol Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Adenoviridae / Interleukin-4 / Leishmaniasis, Cutaneous / Leishmania major / Interleukin-12 / Genetic Vectors Limits: Animals Language: En Journal: J Immunol Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States